ArticleBioengineering & translational medicine2021

Targeted systemic dendrimer delivery of CSF-1R inhibitor to tumor-associated macrophages improves outcomes in orthotopic glioblastoma.

Kevin Liaw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.